The Red Couch: Season 4
This season journeys across six of Johnson & Johnson’s strategic focus areas: Cardiopulmonary/Cardiovascular, Immunology, Neuroscience, Vision, Oncology and Surgery.
Each episode explores a different dimension of healthcare innovation, not through product alone, but through the people driving it forward. You’ll meet scientists pushing the boundaries of what’s possible. Healthcare professionals delivering extraordinary care. Partners expanding what’s possible through collaboration. Patients whose stories remind us why this work matters. And creators helping translate complex science into conversations that reach people where they are.
From cultural moments and unexpected collaborations to deeply personal patient journeys, Season Four demonstrates that innovation isn’t only about what’s discovered. It’s about what’s understood. Because when science connects with storytelling, innovation becomes something people can see, feel, and believe in.
Each episode explores a different dimension of healthcare innovation, not through product alone, but through the people driving it forward. You’ll meet scientists pushing the boundaries of what’s possible. Healthcare professionals delivering extraordinary care. Partners expanding what’s possible through collaboration. Patients whose stories remind us why this work matters. And creators helping translate complex science into conversations that reach people where they are.
From cultural moments and unexpected collaborations to deeply personal patient journeys, Season Four demonstrates that innovation isn’t only about what’s discovered. It’s about what’s understood. Because when science connects with storytelling, innovation becomes something people can see, feel, and believe in.
Episode 1 | Neuroscience: When “fine” is not enough
Mental health has become one of the defining conversations of our time. Yet for millions of people, especially younger generations, one phrase continues to mask what they’re truly experiencing: “I’m fine.”
This season opens with Generation Fine, Johnson & Johnson’s above-brand campaign challenging the culture of silent struggle and encouraging more honest conversations around mental health. More than a campaign, Generation Fine demonstrates how storytelling, creator voices, and authentic lived experiences can help break through in ways traditional communications cannot. It’s a powerful reminder that innovation isn’t always measured in medicines or devices. Sometimes, it’s measured in conversations. Because when we create space for people to say, “I’m not fine,” we create the possibility for healing to begin.
This season opens with Generation Fine, Johnson & Johnson’s above-brand campaign challenging the culture of silent struggle and encouraging more honest conversations around mental health. More than a campaign, Generation Fine demonstrates how storytelling, creator voices, and authentic lived experiences can help break through in ways traditional communications cannot. It’s a powerful reminder that innovation isn’t always measured in medicines or devices. Sometimes, it’s measured in conversations. Because when we create space for people to say, “I’m not fine,” we create the possibility for healing to begin.
-
The Red Couch_Season 4, Episode 1_ Neuroscience
Vanessa Broadhurst
Vanessa Broadhurst is Executive Vice President, Global Corporate Affairs at Johnson & Johnson. As a member of the Executive Committee, Vanessa is responsible for advancing strategies across Corporate Marketing, Communications, Global Health Equity, and Worldwide Government Affairs & Policy.
Vanessa serves as a director of Zoetis and is a leadership council member for the Rutgers Cancer Institute. She is a former director of The Ad Council.
Prior to her current position, Vanessa served as Company Group Chairman, Global Commercial Strategy for Johnson & Johnson’s Innovative Medicine sector where she led efforts focused on pipeline development, commercialization, and launch strategies, realizing accelerated business growth across six therapeutic areas. In this role, Vanessa was a member of the Pharmaceuticals Group Operating Committee, the Research and Development Senior Leadership Team, and responsible for Global Marketing, Value and Access, Commercial Data Sciences, and Global Medical Affairs. Previously, Vanessa successfully led large in-line U.S. and global businesses at leading global healthcare companies in the U.S. and Europe including J&J, Amgen, Novartis and Abbott.
Vanessa serves as a director of Zoetis and is a leadership council member for the Rutgers Cancer Institute. She is a former director of The Ad Council.
Prior to her current position, Vanessa served as Company Group Chairman, Global Commercial Strategy for Johnson & Johnson’s Innovative Medicine sector where she led efforts focused on pipeline development, commercialization, and launch strategies, realizing accelerated business growth across six therapeutic areas. In this role, Vanessa was a member of the Pharmaceuticals Group Operating Committee, the Research and Development Senior Leadership Team, and responsible for Global Marketing, Value and Access, Commercial Data Sciences, and Global Medical Affairs. Previously, Vanessa successfully led large in-line U.S. and global businesses at leading global healthcare companies in the U.S. and Europe including J&J, Amgen, Novartis and Abbott.
